Quest Diagnostics Cash on Hand 2010-2024 | DGX

Quest Diagnostics cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Quest Diagnostics cash on hand for the quarter ending March 31, 2024 was $0.474B, a 170.86% increase year-over-year.
  • Quest Diagnostics cash on hand for 2023 was $0.686B, a 117.78% increase from 2022.
  • Quest Diagnostics cash on hand for 2022 was $0.315B, a 63.88% decline from 2021.
  • Quest Diagnostics cash on hand for 2021 was $0.872B, a 24.7% decline from 2020.
Quest Diagnostics Annual Cash on Hand
(Millions of US $)
2023 $686
2022 $315
2021 $872
2020 $1,158
2019 $1,192
2018 $135
2017 $137
2016 $359
2015 $133
2014 $192
2013 $187
2012 $296
2011 $165
2010 $449
2009 $534
Quest Diagnostics Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $474
2023-12-31 $686
2023-09-30 $143
2023-06-30 $126
2023-03-31 $175
2022-12-31 $315
2022-09-30 $700
2022-06-30 $790
2022-03-31 $712
2021-12-31 $872
2021-09-30 $987
2021-06-30 $560
2021-03-31 $1,230
2020-12-31 $1,158
2020-09-30 $1,605
2020-06-30 $988
2020-03-31 $342
2019-12-31 $1,192
2019-09-30 $434
2019-06-30 $273
2019-03-31 $464
2018-12-31 $135
2018-09-30 $263
2018-06-30 $132
2018-03-31 $124
2017-12-31 $137
2017-09-30 $350
2017-06-30 $314
2017-03-31 $367
2016-12-31 $359
2016-09-30 $406
2016-06-30 $283
2016-03-31 $128
2015-12-31 $133
2015-09-30 $123
2015-06-30 $150
2015-03-31 $974
2014-12-31 $192
2014-09-30 $170
2014-06-30 $144
2014-03-31 $144
2013-12-31 $187
2013-09-30 $158
2013-06-30 $148
2013-03-31 $134
2012-12-31 $296
2012-09-30 $192
2012-06-30 $174
2012-03-31 $145
2011-12-31 $165
2011-09-30 $111
2011-06-30 $184
2011-03-31 $994
2010-12-31 $449
2010-09-30 $369
2010-06-30 $448
2010-03-31 $463
2009-12-31 $534
2009-09-30 $247
2009-06-30 $119
2009-03-31 $204
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.220B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.341B 0.00
DaVita (DVA) United States $12.098B 15.03
Encompass Health (EHC) United States $8.595B 22.00
Chemed (CHE) United States $8.221B 25.48
Elanco Animal Health (ELAN) United States $6.286B 16.31
Option Care Health (OPCH) United States $5.272B 19.95
RadNet (RDNT) United States $4.581B 95.39
Amedisys (AMED) United States $3.189B 22.59
Astrana Health (ASTH) United States $2.762B 37.37
Addus HomeCare (ADUS) United States $2.150B 27.83
LifeStance Health (LFST) United States $2.103B 0.00
U.S Physical Therapy (USPH) United States $1.423B 38.08
Pennant (PNTG) United States $0.815B 43.08
Aveanna Healthcare Holdings (AVAH) United States $0.662B 0.00
Atai Life Sciences (ATAI) Germany $0.248B 0.00
Daxor (DXR) United States $0.046B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.013B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00